Targeting the ATG5-ATG16L1 Protein–Protein Interaction with a Hydrocarbon-Stapled Peptide Derived from ATG16L1 for Autophagy Inhibition
Journal of the American Chemical Society2022Vol. 144(38), pp. 17671–17679
Citations Over TimeTop 10% of 2022 papers
Jin Cui, Yuta Ogasawara, Ikuko Kurata, Kazuaki Matoba, Yūko Fujioka, Nobuo N. Noda, Masakatsu Shibasaki, Takumi Watanabe
Abstract
Selective modulation of autophagy is a promising therapeutic strategy, especially for cancer treatment. However, the lack of specific autophagy inhibitors limits this strategy. The formation of the ATG12-ATG5-ATG16L1 complex is essential for targeting the ATG12-ATG5 conjugate to proper membranes and to generate LC3-II for the progression of autophagy. Thus, targeting ATG5-ATG16L1 protein-protein interactions (PPIs) might inhibit early stage autophagy with high specificity. In this paper, we report that a stapled peptide derived from ATG16L1 exhibits potent binding affinity to ATG5, striking resistance to proteolysis, and significant autophagy inhibition activities in cells.
Related Papers
- → Dram1 regulates DNA damage-induced alternative autophagy(2018)49 cited
- → Autophagy Functions to Prevent Methylglyoxal-Induced Apoptosis in HK-2 Cells(2020)13 cited
- → Nutrient Modulation of Autophagy(2012)6 cited
- → SS-31 inhibits the inflammatory response by increasing ATG5 and promoting autophagy in lipopolysaccharide-stimulated HepG2 cells(2024)3 cited
- → Aberrant expression of autophagy markers during osteoarthritis(2013)